PROGNOSTIC SIGNIFICANCE OF SERUM BILIRUBIN IN STROKE
Abstract
Background: Oxidative injury is an important cause of the neurologic lesion in stroke. Serum bilirubinis considered a natural antioxidant that may affect the prognosis of stroke. The purpose of this studywas to evaluate the prognostic significance of bilirubin in stroke patients. Methods: A prospectivecross-sectional study was conducted in Medical Units of Khyber Teaching Hospital, Peshawar.Inpatients admitted with acute attack of stroke were included in this study. Data regarding serumbilirubin and concurrent cerebrovascular risk factors were collected. National Institutes of HealthStroke Scale (NIHSS) and modified Rankin Scale (mRS) were used to analyse stroke’s severity andfunctional outcomes, respectively. Results: Hypertension, diabetes mellitus and heart diseases were themost common risk factors. Patients were divided into 3 groups on the basis of serum bilirubin, i.e., ≤0.6mg/dl (Group-1), 0.7–0.9 mg/dl (Group-2), and ≥1.0 mg/dl (Group-3). The mean pre-hospitalisationNIHSS score for Groups 1, 2 and 3 was 5.62, 11.66 and 25.33, respectively; and post-hospitalisationscore was 0.875, 3.76 and 16.26, respectively. The pre-hospitalisation mRS score was 4 for Group-1,4.52 for Group-2 and 4.93 for Group-3; while post-hospitalisation Mrs Score was 1.50, 2.38 and 4.26,respectively. Average serum bilirubin level was significantly higher in patients with poor outcomes ascompared with good outcomes (p<0.01). Conclusions: This study suggests that higher serum bilirubinlevels were associated with increased stroke severity, longer hospitalisation and poor prognosis.Keywords: Stroke severity, stroke outcome, stroke prognosis, serum bilirubin, National Institutes ofHealth Stroke Scale (NIHSS), modified Rankin Scale (mRS)References
Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie
K, et al. Guidelines for prevention of stroke in patients with
ischemic stroke or transient ischemic attack: a statement for
healthcare professionals from the American Heart
Association/American Stroke Association Council on Stroke: cosponsored by the Council on Cardiovascular Radiology and
Intervention: the American Academy of Neurology affirms the
value of this guideline. Circulation 2006;113(10):e409–49.
Feigin VL. Stroke epidemiology in the developing world. Lancet
;365:2160–1.
Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet
;371:1612–23.
Khealani BA, Hameed B, Mapari UU. Stroke in Pakistan. J Pak
Med Assoc 2008;58:4003.
Jafar TH. Blood pressure, diabetes, and increased dietary salt
associated with stroke--results from a community-based study in
Pakistan. J Hum Hypertens 2006;20(1):83-5.
J Ayub Med Coll Abbottabad 2011;23(2)
http://www.ayubmed.edu.pk/JAMC/23-2/Arsalan.pdf 107
Ollinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, et al.
Bilirubin: a natural inhibitor of vascular smooth muscle cell
proliferation. Circulation 2005;112:1030–9.
Arsalan H, Ismail M, Anwar MJ, Murtaza Z, Khan F.
Relationship of serum albumin with the severity and outcomes of
stroke. Archives of Pharmacy Practice 2011;2(4):158–62.
Shekeeb Shahab M, Kumar P, Sharma N, Narang A, Prasad R.
Evaluation of oxidant and antioxidant status in term neonates: a
plausible protective role of bilirubin. Molecular and cellular
biochemistry 2008;317(1–2):51–9.
Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder
SH. Bilirubin and glutathione have complementary antioxidant
and cytoprotective roles. Proc Natl Acad Sci USA
;106:5171–6.
Sarady-Andrews JK, Liu F, Gallo D, Nakao A, Overhaus M,
Ollinger R, et al. Biliverdin administration protects against
endotoxin-induced acute lung injury in rats. Am J Physiol Lung
Cell Mol Physiol 2005;289:L1131–7.
Syapin PJ. Regulation of haeme oxygenase-1 for treatment of
neuroinflammation and brain disorders. Br J Pharmacol
;155:623–40.
Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA.
Serum total bilirubin level, prevalent stroke, and stroke
outcomes: NHANES 1999–2004. Am J Med 2008;121:781–8e1.
Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an
independent predictor of stroke incidence: a prospective study in
Korean men and women. Stroke 2009;40:3422–7.
Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie
K, et al. Guidelines for prevention of stroke in patients with
ischemic stroke or transient ischemic attack: a statement for
healthcare professionals from the American Heart
Association/American Stroke Association Council on Stroke: cosponsored by the Council on Cardiovascular Radiology and
Intervention: the American Academy of Neurology affirms the
value of this guideline. Stroke 2006;37:577–617.
NIH Stroke Scale (NIHSS). Available at:
http://www.nihstrokescale.org/docs/NIH_Stroke_Scale.pdf.
Accessed October 20, 2010.
Modified Rankin Scale (mRS). Available at:
http://www.strokecenter.org/trials/scales/modified_rankin.pdf.
Accessed October 20, 2010.
Sedlak TW, Snyder SH. Bilirubin benefits: cellular protection by
a biliverdin reductase antioxidant cycle. Pediatrics
;113:1776–82.
Regino WO, Velasco H, Sandoval H. The protective role of
bilirubin in human beings. Revista Colombiana de
Gastroenterologia 2009;24:293–301.
Pineda S, Bang OY, Saver JL, Starkman S, Yun SW, Liebeskind
DS, et al. Association of serum bilirubin with ischemic stroke
outcomes. J Stroke Cerebrovasc Dis 2008;17(3):147–52.
Dohi K, Mochizuki Y, Satoh K, Jimbo H, Hayashi M, Toyoda I,
et al. Transient elevation of serum bilirubin (a heme oxygenase-1
metabolite) level in hemorrhagic stroke: bilirubin is a marker of
oxidant stress. Acta Neurochir Suppl 2003;86:247–9.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
